Efficacy and safety of FLOT combined with apatinib and sintilimab as a neoadjuvant therapy regimen for locally advanced gastric or gastroesophageal junction adenocarcinoma: An open-lable, single-arm, phase II study

被引：1

作者：

Zhou, H. ^{[1
]}

Long, B. ^{[2
]}

Yu, Z. ^{[3
]}

Zhu, J. ^{[2
]}

Yang, H. ^{[4
]}

Zhang, W. ^{[3
]}

Guan, X. ^{[5
]}

Zhang, G. ^{[2
]}

Li, L. ^{[2
]}

Luo, C. ^{[2
]}

Cao, H. ^{[2
]}

Zhang, S. ^{[2
]}

Chen, S. ^{[2
]}

He, Q. ^{[2
]}

Gan, S. ^{[2
]}

Zhou, L. ^{[2
]}

Jiang, X. ^{[2
]}

Shi, W.

Huang, Z. ^{[5
]}

Mao, J. ^{[2
]}

Dong, C. ^{[6
]}

Jiao, Z. ^{[2
]}

机构：

[1] Gansu Prov Canc Hosp, Dept Abdominal Surg, Lanzhou, Peoples R China

[2] Lanzhou Univ Second Hosp, Dept Gen Surg, Lanzhou, Peoples R China

[3] Lanzhou Univ Second Hosp, Dept Radiol, Lanzhou, Peoples R China

[4] Lanzhou Univ Second Hosp, Cuiying Cent Lab, Lanzhou, Peoples R China

[5] Lanzhou Univ Second Hosp, Dept Gastroenterol, Lanzhou, Peoples R China

[6] Lanzhou Univ Second Hosp, Dept Pathol, Lanzhou, Peoples R China

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.04.202

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-146

引用

页码：S66 / S67

页数：2

共 50 条

[21] Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: early results of a phase 2 study
Jiang, Haiping
Yu, Xiongfei
Li, Ning
Kong, Mei
Ma, Zhimin
Zhou, Donghui
Wang, Weibin
Wang, Haohao
Wang, Haiyong
He, Kuifeng
Li, Zhongqi
Lu, Yimin
Zhang, Jing
Zhao, Kui
Zhang, Yafei
Xu, Nong
Li, Ziran
Liu, Ying
Wang, Yan
Wang, Yisen
Teng, Lisong
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
[22] Perioperative camrelizumab combined with chemotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: A single-arm, single-center, phase II clinical trial
He, J.
Yang, Y.
Zhou, S.
Zhang, B.
Han, Z.
Wu, T.
Qiao, Q.
Yang, H.
He, X.
Wang, N.
ANNALS OF ONCOLOGY, 2023, 34 : S1549 - S1549
[23] Efficacy and Safety of Sintilimab in Combination with Concurrent Chemoradiotherapy for Locally Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (SHARED): Study Protocol of a Prospective, Multi-Center, Single-Arm Phase 2 Trial
Wei, Jia
Lu, Xiaofeng
Liu, Qin
Fu, Yao
Liu, Song
Li, Lin
Liu, Fangcen
Fan, Xiangshan
Yang, Ju
Yang, Yang
Zhao, Yang
Guan, Wenxian
Liu, Baorui
CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2007 - 2015
[24] Fruquintinib combined with sintilimab and SOX as conversion therapy for unresectable locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma (GC/GEJC): A single-arm, open-label, phase 2 clinical trial.
Ma, Fei
Luo, Suxia
Zhang, Bin
Ma, Qi
Ji, Sheqing
Zhang, Zhandong
Zhang, Yonglei
Yang, Wei
Peng, Liangqun
Guo, Dandan
Ren, Jinjun
Zhang, Yuan
Su, Yueyue
Li, Jing
Liu, Wentao
Huang, Jinxi
Yuan, Weiwei
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[25] Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
Shi, Jinming
Li, Ning
Tang, Yuan
Jiang, Liming
Yang, Lin
Wang, Shulian
Song, Yongwen
Liu, Yueping
Fang, Hui
Lu, Ningning
Qi, Shunan
Chen, Bo
Li, Ziyu
Liu, Shixin
Wang, Jun
Wang, Wenling
Zhu, Suyu
Yang, Jialin
Li, Yexiong
Zhao, Dongbing
Jin, Jing
BMC GASTROENTEROLOGY, 2022, 22 (01)
[26] Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
Jinming Shi
Ning Li
Yuan Tang
Liming Jiang
Lin Yang
Shulian Wang
Yongwen Song
Yueping Liu
Hui Fang
Ningning Lu
Shunan Qi
Bo Chen
Ziyu Li
Shixin Liu
Jun Wang
Wenling Wang
Suyu Zhu
Jialin Yang
Yexiong Li
Dongbing Zhao
Jing Jin
BMC Gastroenterology, 22
[27] Efficacy and safety of camrelizumab combined with FLOT versus FLOT alone as neoadjuvant therapy in patients with resectable locally advanced gastric and gastroesophageal junction adenocarcinoma who received D2 radical gastrectomy
Min, L. Z.
Liu, N.
Zhou, Y.
Niu, Z.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S1106 - S1106
[28] Camrelizumab combined with FLOFOX as neoadjuvant therapy for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma: Updated results of efficacy and safety.
Liu, Ying
Han, Guangsen
Li, Hongle
Zhao, Yuzhou
Li, Zhi
Zhuang, Jing
Wang, Gangcheng
Li, Baodong
Wang, Jinbang
Li, Zhimeng
Xia, Qingxin
Zhang, Chengjuan
Yu, Juan
Li, Ke
Xu, Shuning
Qiao, Lei
Kuang, Gaizhen
Li, Danyang
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[29] SOX combined with tislelizumab and low-dose radiation therapy for the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase Ib/II clinical trial
Zhang, Peng-Fei
Chen, Ye
Li, Wen-Ke
Luo, Zhu-Mei
Chen, Ji
Qian, Kun
Chen, Xiao-Dong
Wang, Mo-Jin
Liu, Ming
FRONTIERS IN IMMUNOLOGY, 2024, 15
[30] Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study
Jin Li
Shukui Qin
Lu Wen
Junsheng Wang
Wenying Deng
Weijian Guo
Tongfu Jia
Da Jiang
Guifang Zhang
Yifu He
Yi Ba
Haijun Zhong
Lin Wang
Xiaoyan Lin
Jianwei Yang
Jun Zhao
Yuxian Bai
Xiangyuan Wu
Feng Gao
Guogui Sun
Yongjuan Wu
Feng Ye
Qiong Wang
Zhong Xie
Tienan Yi
Yong Huang
Guohua Yu
Lin Lu
Ying Yuan
Wei Li
Likun Liu
Yuping Sun
Ying Sun
Lifeng Yin
Zhiguo Hou
BMC Medicine, 21

← 1 2 3 4 5 →